[Click here to JOIN and get our WEEKLY newsletter!!]

Akzo hints at separating pharma division
Financial Times (subscription), UK - Jul 18, 2003
... But the loss of patent protection on Remeron, its top-selling antidepressant,
sent the unit's first-half operating profits down 13 per cent. ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update5)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update4)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update3)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update2)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Nobel's quarterly profits slide
... currencies and pensions. Pharma sales were impacted by generic competition
to our key drug Remeron in the United States. Net income ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update1)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Nobel Shares Rise as Second-Quarter Profit Beats Estimates
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Nobel unveils a 25% fall in profits
Financial Times (subscription), UK - Jul 18, 2003
... The fall, which was in line with expectations, was mainly a result of cheap generic
competition for Remeron, its antidepressant that has lost its patent ...

Akzo's 2nd-Qtr Profit Sinks 28% as Drug Sales Slip (Update2)
Bloomberg - Jul 18, 2003
... Akzo Nobel NV, the largest Dutch drugmaker, posted a 28 percent decline in second-quarter
profit as cheaper generics eroded sales of its antidepressant Remeron ...

EUROPE MARKETS
CBS MarketWatch - Jul 18, 2003
... Its pharma operating income fell 25 percent due to generic Remeron competition in
the United States, coatings fell 12 percent and chemicals were off 14 percent ...

Akzo Nobel's 2nd-Quarter Profit Sinks 28% as Drug Sales Decline
Bloomberg - Jul 18, 2003
... Akzo Nobel NV, the largest Dutch drugmaker, posted a 28 percent decline in second-quarter
profit as cheaper generics eroded sales of its antidepressant Remeron ...

Akzo Nobel earnings in line with expectations
Pressi.com (press release) - Jul 17, 2003
... currencies and pensions. Pharma sales were impacted by generic competition
to our key drug Remeron in the United States. Net income ...

Antipsychotic Drug Can Help Halt Anorexics’ Frantic Quest to ...
ABC News - Jul 3, 2003
... small dose of mitarpizine," Blinder said. Mitarpizine, an antidepressant,
is marketed as Remeron. One problem with this treatment ...

Dissolving drugs, growing profits for Cima Labs
Akron Beacon Journal, OH - Jun 22, 2003
... Cima's largest source of revenue in the first quarter came from Remeron SolTab,
a prescription anti-depressant developed by pharmaceutical concern Organon. ...

Dissolving drugs, growing profits for Cima Labs
Wichita Eagle, KS - Jun 22, 2003
... Cima's largest source of revenue in the first quarter came from Remeron SolTab,
a prescription anti-depressant developed by pharmaceutical concern Organon. ...

Dissolving drugs, growing profits for Cima Labs
Fort Wayne News Sentinel, IN - Jun 22, 2003
... Cima's largest source of revenue in the first quarter came from Remeron SolTab,
a prescription anti-depressant developed by pharmaceutical concern Organon. ...

Dissolving drugs, growing profits for Cima Labs
Kansas City Star, MO - Jun 22, 2003
... Cima's largest source of revenue in the first quarter came from Remeron SolTab,
a prescription anti-depressant developed by pharmaceutical concern Organon. ...

Dissolving drugs, growing profits for Cima Labs
Miami Herald, FL - Jun 22, 2003
... Cima's largest source of revenue in the first quarter came from Remeron SolTab,
a prescription anti-depressant developed by pharmaceutical concern Organon. ...